Cellular Toxicity of Nanogenomedicine in MCF-7 Cell Line: MTT assay

Cytotoxicity of the futuristic nanogenomedicine (e.g., short interfering RNA and antisense) may hamper its clinical development. Of these, the gene-based medicine and/or its carrier may elicit cellular toxicity. For assessment of such cytotoxicity, a common methodology is largely dependent upon util...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadian, Somaieh, Barar, Jaleh, Saei, Amir Ata, Fakhree, Mohammad Amin Abolghassemi, Omidi, Yadollah
Formato: Texto
Lenguaje:English
Publicado: MyJove Corporation 2009
Materias:
Basic Protocols
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791085/
https://www.ncbi.nlm.nih.gov/pubmed/19352311
http://dx.doi.org/10.3791/1191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791085/
https://www.ncbi.nlm.nih.gov/pubmed/19352311
http://dx.doi.org/10.3791/1191

Ejemplares similares